Small Molecules Technology Platform Brochure

Small Molecule Full-Service Partner of Choice from Advanced Intermediates to Drug Products

• Integrated network of cGMP facilities across Europe and US
• 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction
• Clinical (Phase I-III) and ongoing commercial supply to multiple markets around the world (including US, Europe and Japan)
• Kilo to Multi-ton production volumes per annum
• Process development capabilities (including flow / continuous manufacturing)
• All sites FDA and EMEA approved facilities with long history of successful regulatory and customer audits
• Strong EHS programs in place at sites